This page shows the latest diagnostics news and features for those working in and with pharma, biotech and healthcare.
The companies aim to double diagnostic rates for those with advanced to severe forms of the disease by 2025. ... The companies aim to double diagnostic rates for people living with advanced to severe NASH by 2025.
They also tested the approach with data from over 80 patients undergoing diagnostic tests for Alzheimer’s at Imperial College Healthcare NHS Trust.
A new partnership between LifeArc and the UK Dementia Research Institute (UK DRI) has been announced to accelerate the development of new diagnostic tests, treatments and devices to benefit people with ... The partnership will allow UK DRI scientists
The news of the platform is part of Genomic’s England’s Cancer 2.0 strategy which aims to shorten the diagnostic times for people with cancer, help clinicians deliver personalised
This is why we have been early supporters of ATOM, working closely with our coalition partners to find the best ways to combine our expertise and strengths in diagnostics and pharmaceuticals
Roche, through its Global Access Program, and The Global Fund are teaming up to build and reinforce diagnostic capacity and pandemic preparedness in low- and middle-income countries (LMICs) to help ... He added: “We are pleased to partner with Roche in
More from news
Approximately 38 fully matching, plus 667 partially matching documents found.
The route to diagnosis. Often described as the ‘diagnostic odyssey’, the route to correct diagnosis can be complex and drawn out.
Ashfield regularly focuses on emerging medicines, technologies and diagnostics that can improve future healthcare and that can lead to working in ‘unchartered territory’ where the boundaries of creativity and innovation are
Assessment of the literature and insights from the authors indicated that diagnostic data is often reported in a text and/or tabular form that can pose barriers to the speed and
industry (26%) and diagnostic companies (25%) since the outbreak.
6. Over-production – unnecessary diagnostic testing is an area for waste reduction; time will tell which pathways, that have been adversely affected by COVID-19 delays, have managed to maintain clinical
More from intelligence
Approximately 3 fully matching, plus 159 partially matching documents found.
He has over 30 years of experience working in the healthcare/pharmaceutical industries, having worked with clients including AstraZeneca, the Department of Health, Johnson &Johnson, NHS England, Novartis, Roche Diagnostics and
Lee (pictured below) has over 20 years of global and UK-based healthcare experience in both corporate and brand communications for a number of pharma, biotech, diagnostic and health companies.
An expert in cell and gene therapies, Dr Ferrari joins emotive following 20 years in research as well as holding medical affairs and commercial roles in biopharma and diagnostics.
diagnostics, new drugs, and new treatments for millions of patients Worldwide.”.
It focuses on five strategic areas: biological diagnostics, diagnostic and interventional imaging, regenerative medicine and biomaterials, digital health and translational medicine.
More from appointments
Approximately 3 fully matching, plus 74 partially matching documents found.
Fiona has a BSc in Medical Physics which involved studying subjects such as Radiotherapy, Nuclear Medicine and Medical Imaging techniques and wrote her dissertation in Ultrasound diagnostics.
9. While initially focussing on fertility and period tracking, it is now expanding to cover everything from pelvic floor health to improving diagnostic rates of certain cancers. ... there are also companies that create products for HCPs (like updated
Bringing together a wide array of stakeholders—from the pharmaceutical and diagnostic industry to providers, payers, patients, and clinicians—is crucial for exchanging perspectives and ideas in this changing landscape.
Among many other things, he will share his insights into how Medical Device and In Vitro Diagnostic companies can get safe, qualitative, and well-performing products onto the EU market with
This provides exciting potential for the future and will hopefully help to end the diagnostic odyssey that rare disease patients commonly face.
More from PMHub
Approximately 10 fully matching, plus 130 partially matching documents found.
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...